BullFrog AI Holdings (BFRGW) Change in Account Payables (2022 - 2025)
BullFrog AI Holdings' (BFRGW) quarterly Change in Account Payables came in at -$61.0 in Q4 2025, down 100.02% on a YoY basis from $344560.0 in Q4 2024, and up 99.55% quarter-over-quarter from -$13581.0 in Q3 2025.
Powered by 
Analysis
BullFrog AI Holdings (BFRGW) Change in Account Payables (2022 - 2025) Analysis & Trends
BullFrog AI Holdings (BFRGW) has reported Change in Account Payables for 4 consecutive years, with -$61.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Change in Account Payables fell 100.02% year-over-year to -$61.0; the trailing twelve-month figure through Dec 2025 stood at -$267783.0 (down 180.59% YoY), and the FY2025 full-year result was -$267783.0, down 180.59% from the prior year.
- Change in Account Payables advanced to -$61.0 in Q4 2025 per BFRGW's latest filing, from -$13581.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $423453.0 in Q4 2022 and bottomed at -$380211.0 in Q3 2023.
- Historically, Change in Account Payables has averaged $6222.3 across 4 years, with a median of -$3454.0 in 2023.
- The sharpest annual moves came in 2023 and 2024: Change in Account Payables plunged 2073.17% in 2023, then soared 5132.28% in 2024.
- Over 4 years, Change in Account Payables stood at $423453.0 in 2022, then plunged by 101.62% to -$6847.0 in 2023, then jumped by 5132.28% to $344560.0 in 2024, then sank by 100.02% to -$61.0 in 2025.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$61.0, -$13581.0, and -$28741.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.66 Bn | 197.67 Bn | 7.24 Bn | -70.00 Mn |
| 2 | Gilead Sciences | 181.20 Bn | 178.03 Bn | 6.22 Bn | 18.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.30 Bn | 124.45 Bn | 2.84 Bn | -66.70 Mn |
| 4 | Regeneron Pharmaceuticals | 82.63 Bn | 74.64 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.60 Bn | 56.41 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.55 Bn | 49.41 Bn | 52.00 Mn | -8.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.01 Bn | 30.71 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.26 Bn | 29.97 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.87 Bn | 29.87 Bn | 1.16 Mn | 7.11 Mn |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -61.00 |
| Sep 30, 2025 | -13,581.00 |
| Jun 30, 2025 | -28,741.00 |
| Mar 31, 2025 | -225,400.00 |
| Dec 31, 2024 | 344,560.00 |
| Sep 30, 2024 | 9,358.00 |
| Jun 30, 2024 | -72,526.00 |
| Mar 31, 2024 | 50,886.00 |
| Dec 31, 2023 | -6,847.00 |
| Sep 30, 2023 | -380,211.00 |
| Jun 30, 2023 | -146,177.00 |
| Mar 31, 2023 | 92,898.00 |
| Dec 31, 2022 | 423,453.00 |
| Sep 30, 2022 | 19,269.00 |
| Jun 30, 2022 | -52,866.00 |
| Mar 31, 2022 | 85,543.00 |